CytoMed Therapeutics
GDTC
#9801
Rank
HK$0.21 B
Marketcap
HK$18.23
Share price
-5.62%
Change (1 day)
8.25%
Change (1 year)

EPS for CytoMed Therapeutics (GDTC)

EPS in 2021: -HK$1.08

According to CytoMed Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$1.08. In 2021 the company made an earnings per share (EPS) of -HK$1.08 a decrease over its 2020 EPS that were of -HK$1.04.

EPS history for CytoMed Therapeutics from 2020 to 2021

Annual EPS

Year EPS Change
2021-HK$1.083.73%
2020-HK$1.04